No article text was recorded for this version.
Alzheimer's disease pathology
Version 1 of 1109 papers141 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Unvalidated efficacy and significant risks hinder clinical use of deep cervical lymphatic-venous anastomosis for Alzheimer’s disease
- Blog: The Alzheimer’s Knowledge Base: A Knowledge Graph for Alzheimer Disease Research
- Blog: Infusion of hESC derived Immunity‐and‐matrix regulatory cells improves cognitive ability in early‐stage AD mice
- Blog: TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer’s Disease: A Multi-Omics Analysis
- Blog: Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies
- Blog: Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway
- Blog: EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
- Blog: An interventional study of baicalin on neuronal pentraxin-1, neuronal pentraxin-2, and C-reactive protein in Alzheimer’s disease rat model
- Blog: Human DDIT4L intron retention contributes to cognitive impairment and amyloid plaque formation
- Blog: Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
- Blog: Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by <scp>d</scp> -galactose and Aβ <sub>1–</sub> <sub>40</sub> injection in ovariectomized Alzheimer’s disease model rats
- Blog: Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD
- Blog: Chronic oral administration of ibrutinib prevents long-term memory deficits and reduces AD pathology and neuroinflammatory responses in a mouse model of AD
- Blog: Mathematical model on Alzheimer's disease
- Blog: Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease
- Blog: Yuan-Zhi decoction in the treatment of Alzheimer’s disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation
- Blog: ALWPs Improve Cognitive Function and Regulate Aβ Plaque and Tau Hyperphosphorylation in a Mouse Model of Alzheimer’s Disease
- Blog: Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
- Blog: Exploring the Anti-Alzheimer’s Disease Potential of Aspergillus terreus C23-3 Through Genomic Insights, Metabolomic Analysis, and Molecular Docking
- Blog: Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease
- Blog: Overexpression of SFPQ Improves Cognition and Memory in AD Mice
- Blog: Protein Sequence Alignment Algorithm Based on Hybrid Profile Information
- Blog: Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
- Blog: Structure–activity relationship, <i>in vitro</i> and <i>in vivo</i> evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease
- Blog: Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
- Blog: Repurposing non-pharmacological interventions for Alzheimer's disease through link prediction on biomedical literature
- Blog: Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
- Blog: Validation of an Alzheimer's disease assessment battery in Asian participants with mild to moderate Alzheimer's disease.
- Blog: Bibliometric analysis of research on Alzheimer’s disease and non-coding RNAs: Opportunities and challenges
- Blog: A systems‐biology approach to identify candidate genes associated with composite brain pathology scores in the Adult Changes of Thought (ACT) and the Religious Orders Study and Memory and Aging Project (ROSMAP) autopsy cohorts
- Blog: Modulation of β-amyloid aggregation by graphene quantum dots
- Blog: Delayed Anoxic Encephalopathy after Carbon Monoxide Poisoning: Evaluation of Therapeutic Effect by Serial Diffusion-Tensor Magnetic Resonance Imaging and Neurocognitive Test
- Blog: Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data
- Blog: Acquired immunity and Alzheimer's disease
- Blog: The iADRS as an integrated measure of cognition and function: Psychometric evidence from recent clinical trials in early symptomatic Alzheimer's disease
- Blog: Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice
- Blog: Strategies for the use of <i>Ginkgo biloba</i> extract, EGb 761<sup>®</sup>, in the treatment and management of mild cognitive impairment in Asia: Expert consensus
- Blog: Assessment of Baseline Plasma p‐tau217 in TANGO, a Randomized, Placebo‐controlled Phase 2 Study of Gosuranemab in Patients with Early Alzheimer’s Disease
- Blog: 40 Hz transcranial ultrasound stimulation improves cognition and neuroinflammation in female Alzheimer's disease mice
- Blog: A Scoping Review of Oral Chinese Traditional Medicine for Vascular Dementia
- Blog: Kaixin San Jiawei granule improves cognitive function and alleviates neuronal damage in Alzheimer’s disease via multi-component and multi-target mechanisms
- Blog: <scp>NOD2</scp>‐mediated <scp>HDAC6</scp>/<scp>NF</scp>‐κb signalling pathway regulates ferroptosis induced by extracellular histone <scp>H3</scp> in acute liver failure
- Blog: Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging
- Blog: Prediction of 7‐year's conversion from subjective cognitive decline to mild cognitive impairment
- Blog: Geissoschizine methyl ether, a corynanthean-type indole alkaloid from<i>Uncaria rhynchophylla</i>as a potential acetylcholinesterase inhibitor
- Blog: Apelin-13-Mediated Upregulation of METTL3 Ameliorates Alzheimer’s Disease via Inhibiting Neuroinflammation Through m6A-Dependent Regulation of lncRNA BDNF-AS
- Blog: Discovery, Biological Evaluation and Binding Mode Investigation of Novel Butyrylcholinesterase Inhibitors Through Hybrid Virtual Screening
- Blog: Danggui Shaoyao San ameliorates Alzheimer’s disease by regulating lipid metabolism and inhibiting neuronal ferroptosis through the AMPK/Sp1/ACSL4 signaling pathway
- Blog: A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment
- Blog: Double Machine Learning for Block‐Missing Data: Integrative Analysis of Plasma Biomarkers and Hippocampal Atrophy in Alzheimer's Disease Progression
- Blog: The Impact of Natural Compounds on S-Shaped Aβ42 Fibril: From Molecular Docking to Biophysical Characterization
- Blog: Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
- Blog: Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer’s disease
- Blog: Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains
- Blog: Efficacy and safety of ginkgo biloba extract combined with donepezil hydrochloride in the treatment of Chinese patients with vascular dementia: A systematic review meta-analysis
- Blog: Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease
- Blog: NAD <sup>+</sup> - and EVA1-C-dependent reversal of neurological deficits is mediated by differential alternative RNA splicing in tauopathic animal models
- Blog: A machine learning approach to predict amyloid and tau positivity using clinical features
- Blog: Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model
- Blog: Pathology steered stratification network for subtype identification in Alzheimer's disease
Showing 60 of 109 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_alzheimer_s_disease_pathology_c46e137b,
title = {Alzheimer's disease pathology},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/alzheimer-s-disease-pathology/rdr_c46e137bf2f94bb5b5bfd0b7360ae6a8},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_alzheimer_s_disease_pathology_c46e137b_v1,
title = {Alzheimer's disease pathology},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/alzheimer-s-disease-pathology/rdr_c46e137bf2f94bb5b5bfd0b7360ae6a8/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}